ZOM - Zomedica Corp. (ZOM) Q4 2023 Earnings Call Transcript
2024-04-01 20:49:07 ET
Zomedica Corp. (ZOM)
Q4 2023 Earnings Conference Call
April 1, 2024 4:30 PM ET
Company Participants
Elif McDonald - Investor Relations
Larry Heaton - Chief Executive Officer
Peter Donato - Chief Financial Officer
Conference Call Participants
Presentation
Operator
Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to Zomedica's Fourth Quarter and Full-Year 2023 Earnings Release and Business Update Call. I would like to remind everyone that this call is being recorded today, Monday, April 1 at 4.30 PM Eastern Time. And all participants are in listen-only mode. A brief question and-answer session will follow the formal presentation. [Operator Instructions]
I will now turn the call over to Elif McDonald, Investor Relations. Please go ahead Ms. McDonald.
Elif McDonald
Thank you, Paul, and good afternoon ladies and gentlemen. Welcome to Zomedica's fourth quarter and full-year 2023 earnings results and business update call. On today's call, you will hear from Zomedica's CEO, Larry Heaton, and CFO, Peter Donato.
Before we begin, we would like to remind everyone that on this call we will be making various remarks about future expectations, plans and prospects that constitute forward-looking statements.
These forward-looking statements are based on assumptions and there are risks that results may differ materially from those statements. As such Zomedica cannot guarantee that any forward-looking statements will materialize and you are cautioned not to place undue reliance on them. We refer current and potential investors to the forward-looking information and Risk Factor sections of our public filings, available on SEDAR at www.sedar.ca and on EDGAR at sec.gov.
Forward-looking statements made on this conference call represent Zomedica's expectations as of today, Monday April 1, 2024. Finally, we would like to remind everyone that all figures discussed on this call are in United States Dollars....
Zomedica Corp. (ZOM) Q4 2023 Earnings Call Transcript